Dr Aimin Xu: "FGF21-based pharmacotherapy for obesity-related metabolic complications"

~ Eligible for PSL1000H/PSL2000H/PSL4000Y Course Seminar Attendance ~    

Speaker: Aimin Xu, MD, MSc, PhD

Chair and Professor of Metabolic Medicine, Department of Pharmacology and Pharmacy, Department of Medicine, Director, State Key Laboratory of Pharmaceutical Biotechnology, Hong Kong University

Website: https://www.pharma.hku.hk/en/Our-People/Professoriate/Chair-Professor/Professor-Aimin-XU/Professor-Aimin-XU-Profile

 Join Zoom Webinar: https://us06web.zoom.us/j/83144918484

Hosted by the Jin Lab